QUESTIONSWorld Influenza Congress Europe 2009
Venue: Hilton Hotel
| Event Date/Time: Dec 07, 2009 | End Date/Time: Dec 09, 2009 |
| Registration Date: Dec 07, 2009 | |
| Early Registration Date: Oct 02, 2009 |
Report as SpamDescription
Innovation and opportunity for pharma, biotechs, healthcare and investors
World Influenza Congress Europe is the annual conference addressing every aspect of policy and planning, research & development, and stakeholder partnerships.
The World’s largest influenza and antivirals vaccine congress addressing global pandemic trends and key regulatory and industry response to the global H1N1
Major pandemic influenza A(H1N1) vaccine clinical progress and uptake including ongoing H5N1 pandemic and universal vaccine research, production and manufacture and antiviral application
Over 45 sessions covering strategic pandemic influenza preparedness and response with unique industry showcases outlining critical progress in
Regulatory response, industry preparation, H1N1 and H5N1 R&D, antiviral combinations, influenza production, vaccine immunogenicity, novel DNA technology and novel antigen delivery vehicles
Unrivalled global participation from regulators, pharma and biotech with every key player in the influenza market participating
Critical response from Baxter, Crucell, F. Hoffmann-La Roche, GSK Biologicals, Intercell, Novartis Vaccines & Diagnostics, sanofi pasteur, Solvay Biologicals and many more
2009 key speakers include:
* Dr Robin Robinson, Director, BARDA, ASPR, US Department of Health and Human Services
* Dr Klaus Stöhr, Vice President, Global Head, Influenza Strategy Liaison, Novartis Vaccines and Diagnostics
* Dr Hartmut Ehrlich, Vice President, Global Research and Development, Baxter BioScience
* Dr Emmanuel Hanon, Vice President, Influenza Vaccine Franchise, GSK Biologicals
* Dr Derek O'hagan, Vice President and Head of Vaccine Delivery Research, Novartis Vaccines & Diagnostics
* Noel Barrett, Vice President, Research and Development, Baxter BioScience
* Dr Nathalie Garçon, Vice President, Head of Research and North America R&D, GSK Biologicals
* And many more!
Please visit the website for full programme and speaker details. http://www.terrapinn.com/2009/flu/
Venue
Hilton Brussels hotel - 38, Boulevard de Waterloo, Brussels, Belgium 1000
Tel: 32-2-504-1111 Fax: 32-2-504-2111
World Influenza Congress Europe is the annual conference addressing every aspect of policy and planning, research & development, and stakeholder partnerships.
The World’s largest influenza and antivirals vaccine congress addressing global pandemic trends and key regulatory and industry response to the global H1N1
Major pandemic influenza A(H1N1) vaccine clinical progress and uptake including ongoing H5N1 pandemic and universal vaccine research, production and manufacture and antiviral application
Over 45 sessions covering strategic pandemic influenza preparedness and response with unique industry showcases outlining critical progress in
Regulatory response, industry preparation, H1N1 and H5N1 R&D, antiviral combinations, influenza production, vaccine immunogenicity, novel DNA technology and novel antigen delivery vehicles
Unrivalled global participation from regulators, pharma and biotech with every key player in the influenza market participating
Critical response from Baxter, Crucell, F. Hoffmann-La Roche, GSK Biologicals, Intercell, Novartis Vaccines & Diagnostics, sanofi pasteur, Solvay Biologicals and many more
2009 key speakers include:
* Dr Robin Robinson, Director, BARDA, ASPR, US Department of Health and Human Services
* Dr Klaus Stöhr, Vice President, Global Head, Influenza Strategy Liaison, Novartis Vaccines and Diagnostics
* Dr Hartmut Ehrlich, Vice President, Global Research and Development, Baxter BioScience
* Dr Emmanuel Hanon, Vice President, Influenza Vaccine Franchise, GSK Biologicals
* Dr Derek O'hagan, Vice President and Head of Vaccine Delivery Research, Novartis Vaccines & Diagnostics
* Noel Barrett, Vice President, Research and Development, Baxter BioScience
* Dr Nathalie Garçon, Vice President, Head of Research and North America R&D, GSK Biologicals
* And many more!
Please visit the website for full programme and speaker details. http://www.terrapinn.com/2009/flu/
Venue
Hilton Brussels hotel - 38, Boulevard de Waterloo, Brussels, Belgium 1000
Tel: 32-2-504-1111 Fax: 32-2-504-2111
